| Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial MC Garassino, O Martelli, M Broggini, G Farina, S Veronese, E Rulli, ... The lancet oncology 14 (10), 981-988, 2013 | 594 | 2013 |
| Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact C Foroni, M Broggini, D Generali, G Damia Cancer treatment reviews 38 (6), 689-697, 2012 | 375 | 2012 |
| Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy T Bertani, F Cutillo, C Zoja, M Broggini, G Remuzzi Kidney Int 30 (4), 488-496, 1986 | 320 | 1986 |
| Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743 M Minuzzo, S Marchini, M Broggini, G Faircloth, M D'Incalci, R Mantovani Proceedings of the National Academy of Sciences 97 (12), 6780, 2000 | 280 | 2000 |
| Platinum resistance in ovarian cancer: role of DNA repair G Damia, M Broggini Cancers 11 (1), 119, 2019 | 272 | 2019 |
| Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer MC Garassino, M Marabese, P Rusconi, E Rulli, O Martelli, G Farina, ... Annals of oncology 22 (1), 235-237, 2011 | 240 | 2011 |
| PRL-3 phosphatase is implicated in ovarian cancer growth F Polato, A Codegoni, R Fruscio, P Perego, C Mangioni, S Saha, ... Clinical Cancer Research 11 (19), 6835-6839, 2005 | 231 | 2005 |
| Oct‐4 expression in adult human differentiated cells challenges its role as a pure stem cell marker S Zangrossi, M Marabese, M Broggini, R Giordano, M D'Erasmo, ... Stem cells 25 (7), 1675-1680, 2007 | 222 | 2007 |
| p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel D Debernardis, EG Siré, P De Feudis, F Vikhanskaya, M Valenti, P Russo, ... Cancer research 57 (5), 870, 1997 | 205 | 1997 |
| Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia … M Broggini, SV Marchini, E Galliera, P Borsotti, G Taraboletti, E Erba, ... Leukemia 17 (1), 52-59, 2003 | 189 | 2003 |
| Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53 F Vikhanskaya, MK Lee, M Mazzoletti, M Broggini, K Sabapathy Nucleic acids research 35 (6), 2093-2104, 2007 | 183 | 2007 |
| Phospholipase Cγ1 is required for metastasis development and progression G Sala, F Dituri, C Raimondi, S Previdi, T Maffucci, M Mazzoletti, C Rossi, ... Cancer research 68 (24), 10187, 2008 | 181 | 2008 |
| Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects T Maffucci, E Piccolo, A Cumashi, M Iezzi, AM Riley, A Saiardi, ... Cancer research 65 (18), 8339, 2005 | 173 | 2005 |
| CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers F Bertoni, AM Codegoni, D Furlan, MG Tibiletti, C Capella, M Broggini Genes, Chromosomes and Cancer 26 (2), 176-180, 1999 | 159 | 1999 |
| Cisplatinum and taxol induce different patterns of p53 phosphorylation G Damia, L Filiberti, F Vikhanskaya, L Carrassa, Y Taya, M Dincalci, ... Neoplasia 3 (1), 10-16, 2001 | 139 | 2001 |
| p21WAF1-derived Peptides Linked to an Internalization Peptide Inhibit Human Cancer Cell Growth M Bonfanti, S Taverna, M Salmona, M D'Incalci, M Broggini Cancer research 57 (8), 1442-1446, 1997 | 137 | 1997 |
| Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo L Carrassa, R Chilà, M Lupi, F Ricci, C Celenza, M Mazzoletti, M Broggini, ... Cell Cycle 11 (13), 2507-2517, 2012 | 135 | 2012 |
| Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. M Broggini, G Buraggi, A Brenna, L Riva, AM Codegoni, V Torri, ... Anticancer research 20 (6C), 4835, 2000 | 135 | 2000 |
| Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements M Broggini, M Ponti, S Ottolenghi, M D'Incalci, N Mongelli, R Mantovani Nucleic acids research 17 (3), 1051-1059, 1989 | 128 | 1989 |
| p53 regulates the minimal promoter of the human topoisomerase IIα gene MI Sandri, RJ Isaacs, WM Ongkeko, AL Harris, ID Hickson, M Broggini, ... Nucleic acids research 24 (22), 4464-4470, 1996 | 127 | 1996 |
damia giovannaChief, DNA repair unit, Mario negri instituteDirección de correo verificada de marionegri.it
